Promakhos Therapeutics Analysis: $125K Raised
What is Promakhos Therapeutics?
Promakhos Therapeutics develops therapies to restore immune system function, targeting chronic inflammatory diseases like Crohn's disease and multiple sclerosis.
Founded
2021
Revenue
<$5M
Company Stage
Seed
YC Batch
S21
Product Features & Capabilities
- treatments for autoimmune diseases, therapies that restore immune system function, solutions for inflammatory disorders, focus on healing and controlling inflammation
How much Promakhos Therapeutics raised
Pre Seed - $125,000
August 26, 2021Lead Investor: PROTOCOL — by GETTYLAB, Y Combinator
Who are the founders of Promakhos Therapeutics
KC
Katerina Chatzi
Co-founder, Chief Executive Officer and President
JE
Jasper E. Neggers
Co-Founder, Chief Scientific Officer and Secretary
Investors
- Allston Venture Fund
- Asymmetry Ventures
- Pioneer Fund
- Y Combinator
- Metaplanet
- Harvard Venture Incubation Program
